157 related articles for article (PubMed ID: 11427983)
1. Molecular regulation of lymphangiogenesis and targets for tissue oedema.
Karkkainen MJ; Jussila L; Ferrell RE; Finegold DN; Alitalo K
Trends Mol Med; 2001 Jan; 7(1):18-22. PubMed ID: 11427983
[TBL] [Abstract][Full Text] [Related]
2. Lymphangiogenic gene therapy with minimal blood vascular side effects.
Saaristo A; Veikkola T; Tammela T; Enholm B; Karkkainen MJ; Pajusola K; Bueler H; Ylä-Herttuala S; Alitalo K
J Exp Med; 2002 Sep; 196(6):719-30. PubMed ID: 12235206
[TBL] [Abstract][Full Text] [Related]
3. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of lymphangiogenesis in health and disease.
Alitalo K; Carmeliet P
Cancer Cell; 2002 Apr; 1(3):219-27. PubMed ID: 12086857
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis.
Karkkainen MJ; Alitalo K
Semin Cell Dev Biol; 2002 Feb; 13(1):9-18. PubMed ID: 11969367
[TBL] [Abstract][Full Text] [Related]
6. [Genetics of lymphedema: from Milroy's disease to cancer investigations].
Quéré I; Coupé M; Soulier-Sotto V; Evrard-Bras M; Laroche JP; Janbon C
Rev Med Interne; 2002 Jun; 23 Suppl 3():379s-387s. PubMed ID: 12162200
[TBL] [Abstract][Full Text] [Related]
7. Insights into the molecular pathogenesis and targeted treatment of lymphedema.
Saaristo A; Karkkainen MJ; Alitalo K
Ann N Y Acad Sci; 2002 Dec; 979():94-110. PubMed ID: 12543720
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.
Karkkainen MJ; Petrova TV
Oncogene; 2000 Nov; 19(49):5598-605. PubMed ID: 11114740
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.
Mäkinen T; Jussila L; Veikkola T; Karpanen T; Kettunen MI; Pulkkanen KJ; Kauppinen R; Jackson DG; Kubo H; Nishikawa S; Ylä-Herttuala S; Alitalo K
Nat Med; 2001 Feb; 7(2):199-205. PubMed ID: 11175851
[TBL] [Abstract][Full Text] [Related]
11. [Lymphangiogenesis and biological activity ov vascular endothelial growth factor-C].
Mandriota SJ; Pepper MS
J Soc Biol; 1999; 193(2):159-63. PubMed ID: 10451350
[TBL] [Abstract][Full Text] [Related]
12. A model for gene therapy of human hereditary lymphedema.
Karkkainen MJ; Saaristo A; Jussila L; Karila KA; Lawrence EC; Pajusola K; Bueler H; Eichmann A; Kauppinen R; Kettunen MI; Yla-Herttuala S; Finegold DN; Ferrell RE; Alitalo K
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12677-82. PubMed ID: 11592985
[TBL] [Abstract][Full Text] [Related]
13. Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome.
Dagenais SL; Hartsough RL; Erickson RP; Witte MH; Butler MG; Glover TW
Gene Expr Patterns; 2004 Oct; 4(6):611-9. PubMed ID: 15465483
[TBL] [Abstract][Full Text] [Related]
14. Key molecules in lymphatic development, function, and identification.
Jha SK; Rauniyar K; Jeltsch M
Ann Anat; 2018 Sep; 219():25-34. PubMed ID: 29842991
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
16. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic vessels as targets of tumor therapy?
Karpanen T; Alitalo K
J Exp Med; 2001 Sep; 194(6):F37-42. PubMed ID: 11561002
[No Abstract] [Full Text] [Related]
18. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
[TBL] [Abstract][Full Text] [Related]
19. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.
Yoon YS; Murayama T; Gravereaux E; Tkebuchava T; Silver M; Curry C; Wecker A; Kirchmair R; Hu CS; Kearney M; Ashare A; Jackson DG; Kubo H; Isner JM; Losordo DW
J Clin Invest; 2003 Mar; 111(5):717-25. PubMed ID: 12618526
[TBL] [Abstract][Full Text] [Related]
20. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.
Jeltsch M; Kaipainen A; Joukov V; Meng X; Lakso M; Rauvala H; Swartz M; Fukumura D; Jain RK; Alitalo K
Science; 1997 May; 276(5317):1423-5. PubMed ID: 9162011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
